Markets Featured

What Happens When America Stops Drinking?

Americans' drinking rate just hit a 90-year low — and this month the decline moved from survey data to layoffs, bar closures, and multi-year stock lows. The market isn't pricing one alcohol trade. It's deciding who survives a smaller pool of drinkers.

Alpha One

20 Jul 2026 • 7 min read

For most of the past century, betting on American thirst was one of the most reliable trades on Wall Street. Recessions, wars, pandemics — people drank through all of it. Alcohol was the textbook "sin stock": inelastic demand, fat margins, dividends you could set a watch by.

That trade is now breaking in public, and the past two weeks made it hard to ignore. On July 13, the Wall Street Journal reported that Brown-Forman — the maker of Jack Daniel's — and its spirits peers are openly contending with slowing alcohol sales. Days earlier, one of the country's largest Texas-based alcohol distributors announced staff reductions. In Portland, local news is describing a bar scene turning into "a ghost town" as alcohol sales decline. None of these are stories about a bad quarter. They are stories about a customer base that is quietly walking away.

The decline has moved from survey data to the income statement. That transition — from "interesting trend" to "line item" — is the moment investors are paid to notice.

The Numbers Are Historic, Not Cyclical

Start with the demand side, because it is genuinely without precedent in modern American history.

Gallup has asked Americans whether they drink alcohol since 1939 — nearly 90 years of continuous polling. In its latest Consumption Habits survey, just 54% of U.S. adults said they consume alcohol at all. That is the lowest reading in the history of the trend. For a quarter century, from 1997 to 2023, that number never fell below 60%. It hit 62% in 2023, 58% in 2024, and now 54% — consecutive declines Gallup itself calls unmatched in the trend's history. The all-time highs of 68–71% came in the late 1970s.

The composition of the decline matters more than the headline:

Young adults are leading it. Just 50% of 18- to 34-year-olds report drinking, down from 59% in 2023 — and each new cohort is starting from a lower baseline than the one before it.
Women are down 11 points since 2023, to 51%.
The belief system has flipped. For the first time ever, a majority of Americans — 53% — say drinking in moderation is bad for your health. In 2018, only 28% believed that. Just 6% now say moderate drinking is good for you.
It is not substitution. Gallup's own data shows marijuana use has been roughly flat for four years — Americans are not swapping one substance for another. They are simply consuming less.

That last point is the one the industry least wants to hear. A substitution story is a marketing problem. A "we changed our minds about the product's core value" story is a structural one.

Briefings like this land in members' inboxes before the market prices them in. Join free →

Why This Is Happening Now

Three forces converged in roughly a 24-month window, and each one is durable.

The health consensus reversed. For decades, the operating assumption — endorsed by official guidance — was that moderate drinking might even be protective. That view is dead. In January 2025, the U.S. Surgeon General issued a formal advisory linking alcohol to elevated cancer risk and calling for updated warning labels, noting alcohol is among the leading preventable causes of cancer in the United States. The fight over federal dietary guidelines has continued into this summer, with researchers publicly demanding clearer limits. Whatever the final language says, the public already voted: a majority now believes the product is unhealthy at any regular dose.

GLP-1 drugs are quietly shrinking the market. The same appetite-suppressing drugs rewiring food demand appear to suppress alcohol consumption too. A wave of 2025 research — including work published in JAMA-family journals — found that patients on semaglutide-class drugs sharply reduced their drinking, many without intending to. With tens of millions of Americans now on or cycling through these medications, this is no longer a rounding error for beverage companies. It is an involuntary national moderation program.

Generational replacement is doing the rest. The heaviest-drinking cohorts in American history — the ones who set those 1970s participation records — are aging out of peak consumption. The cohorts replacing them drink less, drink less often, and increasingly don't drink at all. Nothing about that reverses on a marketing budget.

The Market Isn't Selling "Alcohol." It's Re-Sorting It.

Here is where it gets interesting for investors, because the equity market is not treating this as one trade.

Over the past twelve months, through Friday's close:

Constellation Brands (STZ): down roughly 22%, trading near $133 — a two-year low, and roughly half its 2024 peak.
Diageo (DEO): down roughly 19%, near $84 against a two-year high above $140.
Brown-Forman (BF.B): down roughly 12%, at about $26 versus nearly $50 two years ago.
Molson Coors (TAP): down roughly 19%.
Boston Beer (SAM): down roughly 8%, less than half its two-year high.

And then the outlier: Anheuser-Busch InBev (BUD) is up roughly 19% over the same twelve months, sitting near two-year highs.

That divergence is the real story. If this were a simple "Americans drink less, sell everything with ethanol in it" repricing, AB InBev would be falling with the rest. It isn't — because the market is distinguishing between business models, not beverages. AB InBev has the most global footprint (the U.S. decline is diluted by markets where drinking isn't collapsing), the deepest premiumization engine, and the most aggressive push into zero-alcohol versions of its flagship brands — capturing the customer who quits alcohol without quitting the ritual. The companies being punished hardest are the ones most exposed to the specific American consumer who is changing fastest.

Constellation deserves special attention as a cautionary tale about catching this knife early. Berkshire Hathaway disclosed a Constellation stake in early 2025 and expanded it into a multi-billion-dollar position — a classic "quality franchise, temporary panic" bet. The stock has since fallen well below those reported entry points. When the most famous value investor on earth is underwater on the trade, the market is telling you it no longer believes this is temporary.

The Damage Doesn't Stop at the Distillery

The second-order exposure is broader than most portfolios assume.

The distribution layer has enormous operating leverage. America's three-tier alcohol system — producer, distributor, retailer — was built for volume growth. Distributors run on thin margins and dense route economics; when volume shrinks, profitability shrinks faster. This month's staff reductions at a major distributor are what that math looks like in practice, and consolidation across the tier is the logical next step.

Bars and restaurants lose their margin engine. Alcohol is the highest-margin item on almost every menu in America — it is frequently what makes the entire P&L work. A customer who orders food and sparkling water is, economically, a different customer. Portland's "ghost town" bar scene is an early data point from a market that leaned harder into drinking culture than most; it will not be the last.

States lose a tax base. Alcohol excise taxes are a small but stable revenue line for every state. A structurally shrinking base joins tobacco in the category of sin-tax revenues that quietly erode budget assumptions.

Someone wins, too. The non-alcoholic segment — zero-proof beers, spirits alternatives, functional beverages — is the one corner of the category growing at double digits from a small base. The strategic question for the majors is whether those products cannibalize their drinkers or retain their quitters. AB InBev's stock suggests the market believes the latter, at least for the company executing best.

What Would Change This Picture

Intellectual honesty requires the counter-case. Some of the current pain is cyclical: a stretched lower-income consumer, post-pandemic normalization from the 2020–2021 at-home drinking bubble, and inventory destocking across the trade all overstate the structural decline. If rates fall and real incomes recover, some volume comes back — people drink more at weddings they can afford to attend.

But the burden of proof has shifted. Watch three things: whether Gallup's participation number stabilizes or takes another leg down in its next annual reading; whether depletions (actual consumer purchases) improve when Diageo reports full-year results in August and Constellation updates guidance; and whether zero-proof growth starts showing up as a measurable offset in the majors' revenue mix rather than a press-release talking point. Until then, treating spirits stocks as cheap defensives misreads what they are: melting franchises priced like stable ones.

The Bottom Line

America's drinking decline is no longer a wellness-culture curiosity. It is a 90-year demand low colliding with an industry structured for permanence — and in July 2026, the costs stopped being theoretical. The market's verdict so far is precise: this is not the end of the alcohol business, but it is the end of the assumption that every alcohol business gets paid just for existing. Scale, global diversification, and a credible zero-proof strategy are being repriced as survival traits. Everything else is being repriced as a value trap.

The sin-stock playbook said people drink no matter what. For the first time in nine decades of data, that is simply no longer true.

If this analysis was useful, this is what AlphaBriefing does every day — geopolitics and markets, connected to what it means for your money. Free members get the daily brief in their inbox; paid members get the investment frameworks, scenario pricing, and catalyst calendars behind the paywall.

Get this level of intelligence every day. Subscribe to AlphaBriefing — free, member, and paid tiers available.

Sources & Further Reading

Disclaimer

AlphaBriefing is an independent intelligence publication. The content in this article is produced for informational and educational purposes only. Nothing published by AlphaBriefing constitutes financial, investment, legal, tax, or regulatory advice, nor should it be construed as a solicitation or recommendation to buy, sell, or hold any security, asset, or financial instrument.

All views expressed are those of the author at the time of writing and are subject to change without notice. Markets are volatile and unpredictable; past performance is not indicative of future results. Any investment involves risk, including the possible loss of principal.

AlphaBriefing and its principals, employees, or contributors may hold positions in securities or assets mentioned in this article. This should be considered a potential conflict of interest. No material relationship with any company referenced exists unless explicitly disclosed. Readers should conduct their own due diligence and consult qualified financial, legal, and tax advisors before making any investment decisions.

Information in this article is drawn from public sources believed to be reliable at the time of publication. AlphaBriefing makes no warranty, express or implied, as to the accuracy, completeness, or timeliness of any information herein. AlphaBriefing accepts no liability for any loss or damage arising from reliance on this content.